All studies
RecruitingTherapeutic confirmatory (Phase III)Interventional

Ketamine Low dOse Evaluation on morphine consumption in traumatic patient

People who suffer serious physical injuries often experience severe pain. Doctors typically treat this with strong opioid medicines like morphine. While opioids work well, large amounts can cause unpleasant problems, such as nausea, confusion, severe constipation, and breathing difficulties. This Phase 3 clinical trial is testing whether adding a low dose of an anaesthetic medicine called ketamine can reduce the total amount of strong opioids a patient needs. Adults admitted to hospital with traumatic injuries will receive either low-dose ketamine or a dummy medicine (a placebo) alongside their usual pain relief. Doctors will measure how much pain medicine each person uses over 48 hours and monitor their comfort, side effects, and recovery time in hospital. They will also check on long-term recovery to see if ketamine helps stop long-lasting pain from developing. The overall goal is to make pain management after trauma safer and more effective.

At a glance

Status
Recruiting
Phase
Therapeutic confirmatory (Phase III)
Sponsor
Assistance Publique Hopitaux De Marseille
Enrolment target
140
Start
31 Jul 2024

What is this study about?

When someone is seriously injured in an accident, getting quick and effective pain relief is crucial. In hospital emergency and intensive care units, doctors usually give strong opioid medications, such as morphine or sufentanil, through a vein. While these medicines are vital for easing severe pain, using high doses carries real risks. Patients may experience extreme drowsiness, slowed breathing, sickness, or confusion, which can slow down recovery.

Ketamine is an established medicine often used in higher doses for surgery anaesthesia. However, when given in very low doses, it works differently. It acts on specific pain receptors in the nervous system to 'turn down' the intensity of pain signals without putting the patient to sleep. Doctors believe that using low-dose ketamine alongside usual treatments might allow them to use far fewer opioids while keeping patients just as comfortable.

This trial compares low-dose ketamine with a harmless dummy medicine (a placebo). By tracking patients closely over their first few days in hospital, the research team wants to see whether ketamine lowers total opioid use, reduces hospital complications, and shortens hospital stays. They will also follow up with patients later on to see if early ketamine treatment helps prevent injuries from turning into chronic, long-term pain.

Key takeaways

  • Tests whether low-dose ketamine helps trauma patients need fewer strong opioid painkillers.
  • Open to adults aged 18 and older admitted to hospital with serious physical injuries.
  • Participants receive either low-dose ketamine or an inactive dummy drip alongside standard pain medicines.
  • Tracks pain control, side effects, recovery speed, and hospital length of stay.
  • Participation is voluntary and does not replace regular pain management.

Who may be eligible?

This study is designed for adults aged 18 and older who have been admitted to hospital following a serious physical trauma or injury and need strong, intravenous pain relief. Men and women of any background can be considered.

Because this study takes place during emergency trauma care, doctors will only include patients who can be safely treated and monitored in the hospital ward or intensive care unit.

People may not be able to join if they have specific medical conditions that make ketamine unsafe. This includes known severe allergies to ketamine, certain pre-existing heart or liver problems, or injuries where ketamine is not recommended. The hospital medical team will carefully review each person's health before enrolling them.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. You are aged 18 or older.
  2. You have been admitted to hospital with a serious physical injury (trauma).
  3. You require strong pain relief through a vein.
  4. You do not have a known allergy or serious medical reason not to take ketamine.
  5. Your hospital doctors confirm that taking part is safe for you.
Answer every question to see your result.

What does participation involve?

Taking part begins when a patient arrives at the hospital needing care for traumatic injuries. Participants are randomly allocated by chance to receive either low-dose ketamine or a matching placebo through a standard intravenous drip (an IV line). Neither the patient nor their bedside care team will know which medicine is being given, ensuring the results are fair and unbiased.

Everyone in the study continues to receive normal, full pain relief whenever they feel pain. Over the first 48 hours and up to five days, nurses and doctors will regularly record pain levels, track the total amount of pain medicine needed, and check for any side effects like nausea or confusion. Total time in intensive care and in the hospital will be noted. After leaving hospital, participants will be asked to complete follow-up questionnaires to see how well they are healing, check their quality of life, and find out if they have any lingering pain.

Potential risks and benefits

The main potential benefit of taking part is needing fewer strong opioids, which could mean fewer side effects such as nausea, bowel problems, or breathing trouble. However, there is no guarantee of direct personal benefit. Low-dose ketamine also carries possible side effects, including brief feelings of confusion, unusual dreams, mild dizziness, or changes in heart rate and blood pressure. All participants are closely monitored by hospital doctors to manage any reactions quickly. Taking part is entirely voluntary, and choosing not to join—or deciding to leave the trial at any time—will never affect the quality of your NHS care or your access to pain relief.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    France

Common questions

Will my pain still be treated if I receive the dummy medicine (placebo)?

Yes. Every participant receives standard pain relief whenever they need it. The study medication is given in addition to standard care, never instead of it.

Will low-dose ketamine put me to sleep or make me hallucinate?

The dose used in this study is very low—far lower than the dose used for surgery anaesthesia. While mild dizziness or strange dreams can happen, it is not meant to make you unconscious.

How is the trial medicine given?

It is given directly into a vein through an intravenous (IV) drip, which is already a normal part of emergency hospital care.

Do I have to pay to take part in this trial?

No. All study medications, tests, and care related to the trial are provided free of charge through the hospital.

Can I leave the study if I change my mind?

Yes. You or your family can withdraw from the study at any point without giving a reason, and your medical team will continue to provide full treatment.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Ketamine Low dOse Evaluation on morphine consumption in trau…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.